Cargando…
Switching and Escalating Therapy in Long-Lasting Multiple Sclerosis: Not Always Necessary
Although therapy switch is common among patients with multiple sclerosis (MS), sometimes the initial prescribed treatment is maintained for a long period with clinical stability, low disability, and nonsignificant side effects. We aim to describe demographic and clinical characteristics of patients...
Autores principales: | Carvalho, Ana Teresa, Sá, Maria José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539327/ https://www.ncbi.nlm.nih.gov/pubmed/23316389 http://dx.doi.org/10.5402/2012/451457 |
Ejemplares similares
-
Primary leiomyosarcoma of the inferior vena cava: Is vascular reconstruction always necessary?
por: Kardoun, Nizar, et al.
Publicado: (2021) -
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study
por: Yadav, Vijayshree, et al.
Publicado: (2012) -
Phonological Fluency Strategy of Switching Differentiates Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Patients
por: Messinis, L., et al.
Publicado: (2013) -
Escalation vs. Early Intense Therapy in Multiple Sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2022) -
APC ain't always necessary for axons
por: Williams, Ruth
Publicado: (2008)